Skip to content

Clinical trials

Endocrine System Diseases trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Endocrine System Diseases Country / region: Netherlands Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20121
20142
20161
20173
20202
20211
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting2
Active, not recruiting1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Maastricht University Medical Center2
Alexion Pharmaceuticals, Inc.1
Ascendis Pharma Endocrinology Division A/S1
Celgene1
Diamyd Medical AB1
Eli Lilly and Company1
Fractyl Health Inc.1
Hoffmann-La Roche1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
Sumitomo Pharma America, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Endocrine System Diseases13
Glucose Metabolism Disorders6
Metabolic Diseases6
Diabetes Mellitus5
Adenocarcinoma4
Diabetes Mellitus, Type 24
Digestive System Neoplasms4
Endocrine Gland Neoplasms4
Neoplasms4
Neoplasms by Site4

Trials

Showing 76 to 13 of 13. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.